SCHEMBL7417568

SCHEMBL7417568

COc1ccc(S(=O)(=O)NCCC(=O)NO)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 3/20 0.71
MMP2 P08253 3/20 0.71
ADAMTS4 O75173 1/20 0.71
MMP14 P50281 1/20 0.71
ADAMTS5 Q9UNA0 1/20 0.71
MEP1B Q16820 2/20 0.68
MMP1 P03956 3/20 0.67
MMP9 P14780 3/20 0.67
ADAM17 P78536 1/20 0.67
USP2 O75604 1/20 0.65
HTT P42858 1/20 0.65
KMT2A Q03164 1/20 0.65
ALDH1A1 P00352 6/20 0.65
PKM P14618 1/20 0.65
KDM4E B2RXH2 1/20 0.64
CYP3A4 P08684 1/20 0.64
CYP2D6 P10635 1/20 0.64
CYP2C19 P33261 1/20 0.64
GAA P10253 1/20 0.62
MAPT P10636 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410575 0.85 MEP1B (0.91) MMP13MMP2ADAMTS4MMP14ADAMTS5
SCHEMBL2945763 0.85 ALDH1A1 (0.69) MEP1BUSP2HTTKMT2AALDH1A1
SCHEMBL7417307 0.83 MMP1 (0.76) MMP13MMP2ADAMTS4MMP14ADAMTS5
SCHEMBL5563528 0.82 ALDH1A1 (0.86) MMP13MMP2MEP1BMMP1MMP9
SCHEMBL7417828 0.81 MEP1B (0.72) MMP13MMP2ADAMTS4MMP14ADAMTS5
SCHEMBL3944045 0.80 ADAM17 (1.00) MMP13MMP2ADAMTS4MMP14ADAMTS5
SCHEMBL6100066 0.80 ALDH1A1 (0.75) MMP13MMP2MEP1BMMP1MMP9
SCHEMBL2677725 0.79 ALDH1A1 (0.74) USP2HTTKMT2AALDH1A1PKM
SCHEMBL5602773 0.79 MMP1 (1.00) MMP1HTTKMT2AALDH1A1SMN1; SMN2
SCHEMBL14365955 0.78 ALDH1A1 (0.63) MMP13MMP2MEP1BMMP1MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed